期刊文献+

P2X7基因C489T和NQ01基因C609T多态性与原发性帕金森病遗传易感性分析 被引量:2

Genetic analysis of P2X7 C489T and NQO1 C609T polymorphisms and susceptibility of primary Parkinson's disease
原文传递
导出
摘要 目的观察嘌呤受体P2X7基因489C>T多态性和依赖还原型辅酶I醌氧化还原酶(NQ01)基因609C>T多态性对散发原发性帕金森病(PD)发病的影响。方法利用Pyrosequenc- ing技术对52例散发原发性PD患者和133例正常健康对照进行P2X7基因489C>T和NQ01基因609C>T突变位点分析。结果PD病例组P2X7 489位点突变型(C/T+T/T)阳性率(88.5%)明显高于对照组(73.7%),差异有统计学意义(x^2=4.73,P<0.05),其患PD的相对危险度(OR)为2.74(95%CI 1.01~7.83)。P2X7 489位点T等位基因频率PD病例组(59.6%)高于对照组(48.1%,x^2=3.95,P<0.05;OR=1.59,95%CI=0.98~2.59)。NQO1 609位点含T碱基的NQO1基因型在PD病例组占61.6%,对照组占49.6%(OR=1.62,95%CI=0.80~3.29)。T等位基因频率PD病例组(33.6%)高于对照组(28.9%,OR=1.25,95%CI=0.74~2.08),但两者差异均无统计学意义。结论P2X7基因489位点C/T和T/T基因型、T等位基因以及NQO1基因609位点T等位基因可能是散发原发性PD发病的危险性因素。 Objective To study whether sporadic primary Parkinson's disease (PD) is associated with genetic polymorphisms of P2X7 489C 〉 T and NQO1 609C 〉 T. Methods The gene polymorphisms of P2X7 and NQO1 in 52 cases of sporadic PD and 133 normal healthy controls were analyzed by using pyrosequencing technique. Results Frequency of P2X7 489 mutation ( C/T + T/T, 88.5% ) in PD cases was significantly higher than that in controls (73.7% ,X2 = 4.73, P 〈 0.05 ). Allele frequencies of T at P2X7 489 site were 59.6% in PD cases and 48.1% in controls, respectively (X^2 = 3.95, P 〈 0.05). C/T + T/T genotypes of P2X7 489C 〉 T had 2.74 of odds ratio (OR) for PD incidence (95% CI 1.01-7.83 ). Allele frequencies of T at NQO1 609 site were 33.6% in PD cases and 28.9% in controls, respectively. Frequencies ( C/T + T/T) of NQO1 609C 〉 T were 61.5% in PD cases and 59, 6% in controis, respectively, which had 1.62 of odds ratio (OR) for incidence of PD (95 % CI 0.80-3.29 ). Con- elusion P2X7 489C 〉 T in C/T and T/T genotypes, T alleles of P2X7 489C 〉 T and NQO1 609C 〉 T might be risk factors of sporadic primary PD pathogenesis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2007年第11期1310-1312,共3页 Chinese Journal of Experimental Surgery
关键词 单核苷酸多态性 帕金森病 基因 Single nucleotide polymorphism Primary Parkinson' s disease Gene
  • 相关文献

参考文献1

二级参考文献1

共引文献8

同被引文献13

  • 1杜卫东,吕永梅,汤华阳,黄叔仁,陈大本,何祥成,王永清,孙松,张学军,徐昌娟(校).Leber遗传性视神经病变线粒体DNA原发性突变位点的分析[J].疾病控制杂志,2006,10(6):574-579. 被引量:9
  • 2汤华阳,杜卫东,张学军.焦磷酸测序技术及应用[J].医学分子生物学杂志,2007,4(3):272-275. 被引量:11
  • 3Siegel D, Gustafson DL, Dehn DL, et al. NAD (P) H : quinone oxi- doreductase 1 :role as a superoxide scavenger. Mol Pharmacol, 2004, 65 : 1238-1247.
  • 4Northwood EL, Elliott F, Forman D, et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics,2010,20:315-326.
  • 5Hong CC ,Ambrosone CB, Ahn J, et al. Genetic variability in iron-re- lated oxidative stress pathways ( Nrf2, NQO1, NOS3, and HO-1 ), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev ,2007,16 : 1784-1794.
  • 6Fagerholm R, Hofstetter B, Tommiska J, et al. NAD (P) H : quinone ox- idoreductase 1 NQO1 * 2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet,2008 ,40 :844-853.
  • 7Ettinger DS. Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific. J Thorac Onco1,2007,2 : 160-165.
  • 8Dong N, Yu J, Wang C, et al. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetax- el plus capecitabine. J Cancer Res Clin 0ncol,2012,138:1197-1203.
  • 9唐先发,杜卫东,张学军,孙中武.帕金森病相关易感基因突变的研究进展[J].国外医学(老年医学分册),2007,28(6):244-249. 被引量:3
  • 10Fabio Coppedè,Michelangelo Mancuso,Gabriele Siciliano,Lucia Migliore,Luigi Murri. Genes and the Environment in Neurodegeneration[J] 2006,Bioscience Reports(5):341~367

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部